Overall rank by patents
#25,379
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A47B (TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE).
The verdict
Ten holds 11 US patents across 6 technology areas, rank #25,379 of 50,000 tracked assignees.
Ten Square Inc. has been granted 11 US utility patents between 2019 and 2024, placing Ten Square Inc. at rank #25,379 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 2.7 claims per patent with primary concentration in A47B (TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE). As a US Corporation, Ten Square Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Ten sits between Tekcem (11 patents, rank #25,375) and Terawave, Inc. (11 patents, rank #25,383) - the closest US assignees by grant volume. The composite Innovation Score of 24.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 10 grants, compared with 1 in the 2015–2019 window, a +900% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ten Square Inc.'s 2.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ten Square Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Tekcem
11 patents
Tekton, Inc.
11 patents
Teledyne Digital Imaging, Inc.
11 patents
Ten Fold Engineering Limited
11 patents
Ten-X, LLC.
11 patents
Tenaris Coiled Tubes, LLC
11 patents
Tenex Health, Inc.
11 patents
Terawave, Inc.
11 patents
Ten Square Inc.
11 patents
What this shows Ten holds 11 patents at rank #25,379, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ten's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 9.1% |
| 2020 | 1 | 9.1% |
| 2021 | 4 | 36.4% |
| 2022 | 2 | 18.2% |
| 2023 | 1 | 9.1% |
| 2024 | 2 | 18.2% |
Top 6 of 6 technology areas
Overall rank by patents
#25,379
Across all tracked assignees
24.4 out of 100
How to use this portfolio
Ten's 11 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.